ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

20/20 Institute Announces Availability of EVO ICL in Denver

By: PRLog
EVO ICL, the Latest Alternative to LASIK, Now Available at Denver's 20/20 Institute

DENVER - Oct. 7, 2025 - PRLog -- 20/20 Institute, Denver's trusted leader in vision correction surgery, proudly announces the addition of EVO ICL (Implantable Collamer® Lens) to its suite of advanced vision correction surgery options. With the launch of EVO ICL, 20/20 Institute continues its mission to empower Coloradans with clear, natural vision—offering a life-changing alternative for those who may not be candidates for LASIK or PRK.

EVO ICL represents the next generation in vision correction surgery, providing a reversible, biocompatible lens that is implanted in the eye to correct nearsightedness and astigmatism. Unlike traditional laser procedures, EVO ICL does not remove corneal tissue, making it an excellent option for patients with thin corneas or high prescriptions.

"At 20/20 Institute, our commitment is to provide the most advanced, personalized vision correction surgery options available," said Dr. Mark S. Danzo, co-founder of 20/20 Institute. "With the introduction of EVO ICL, we're expanding access to clear vision for patients who want freedom from glasses and contacts but may not be ideal candidates for LASIK. Our focus is always on safety, comfort, and delivering exceptional outcomes."

Why Choose EVO ICL at 20/20 Institute?
  • High-Definition Vision: Sharp, vibrant sight—even for strong prescriptions beyond LASIK limits.
  • Preserves Natural Cornea: No tissue removal or reshaping; your eyes stay intact.
  • Reversible & Upgradeable: Lens can be removed or updated as technology advances.
  • Minimal Dry Eye Risk: Keeps cornea untouched, reducing the chance of dryness.
  • Ideal for Thin Corneas: A solution for patients who aren't LASIK candidates.
  • Proven Safety & Satisfaction: Millions implanted worldwide with 99% patient satisfaction.

EVO ICL is ideal for adults aged 21–45 who want crisp, clear vision without the ongoing hassles of glasses or contact lenses. The procedure is quick, comfortable, and provides immediate results—with most patients seeing clearly within hours.

About 20/20 Institute

20/20 Institute is Denver's leading provider of LASIK and advanced vision correction surgery, committed to delivering exceptional outcomes, personalized care, and total transparency. With a focus on innovation, safety, and patient empowerment, the institute has helped thousands achieve life-changing visual freedom.

Ready to take the first step toward clear vision? Schedule your free, no-obligation consultation today or call  720-580-5945 to speak with one of our expert vision counselors.

Photos: (Click photo to enlarge)

EVO ICL Denver


Source: Boulder SEO Marketing

Read Full Story - 20/20 Institute Announces Availability of EVO ICL in Denver | More news from this source

Press release distribution by PRLog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.